![]() |
WEB-based GEne SeT AnaLysis Toolkit |
| Translating gene lists into biological insights... | |
| Database:KEGG pathway       Name:Pathways in cancer       ID:05200 | ||||||
|---|---|---|---|---|---|---|
| C=326; O=5; E=0.62; R=8.07; rawP=0.0004; adjP=0.0033 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000049130 | NA | KITLG | KIT ligand | 4254 | ENSG00000049130 |
| 2  | ENSG00000150630 | NA | VEGFC | vascular endothelial growth factor C | 7424 | ENSG00000150630 |
| 3  | ENSG00000171552 | NA | BCL2L1 | BCL2-like 1 | 598 | ENSG00000171552 |
| 4  | ENSG00000109906 | NA | ZBTB16 | zinc finger and BTB domain containing 16 | 7704 | ENSG00000109906 |
| 5  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| Database:KEGG pathway       Name:Jak-STAT signaling pathway       ID:04630 | ||||||
|---|---|---|---|---|---|---|
| C=155; O=4; E=0.29; R=13.57; rawP=0.0002; adjP=0.0033 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000171552 | NA | BCL2L1 | BCL2-like 1 | 598 | ENSG00000171552 |
| 2  | ENSG00000113594 | NA | LIFR | leukemia inhibitory factor receptor alpha | 3977 | ENSG00000113594 |
| 3  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 4  | ENSG00000112576 | NA | CCND3 | cyclin D3 | 896 | ENSG00000112576 |
| Database:KEGG pathway       Name:Pancreatic cancer       ID:05212 | ||||||
|---|---|---|---|---|---|---|
| C=70; O=3; E=0.13; R=22.54; rawP=0.0003; adjP=0.0033 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000150630 | NA | VEGFC | vascular endothelial growth factor C | 7424 | ENSG00000150630 |
| 2  | ENSG00000171552 | NA | BCL2L1 | BCL2-like 1 | 598 | ENSG00000171552 |
| 3  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| Database:KEGG pathway       Name:Apoptosis       ID:04210 | ||||||
|---|---|---|---|---|---|---|
| C=87; O=3; E=0.17; R=18.14; rawP=0.0006; adjP=0.0037 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000171552 | NA | BCL2L1 | BCL2-like 1 | 598 | ENSG00000171552 |
| 2  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 3  | ENSG00000003400 | NA | CASP10 | caspase 10, apoptosis-related cysteine peptidase | 843 | ENSG00000003400 |
| Database:KEGG pathway       Name:Neurotrophin signaling pathway       ID:04722 | ||||||
|---|---|---|---|---|---|---|
| C=127; O=3; E=0.24; R=12.42; rawP=0.0019; adjP=0.0079 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 2  | ENSG00000118689 | NA | FOXO3 | forkhead box O3 | 2309 | ENSG00000118689 |
| 3  | ENSG00000095015 | NA | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | 4214 | ENSG00000095015 |
| Database:KEGG pathway       Name:Cytokine-cytokine receptor interaction       ID:04060 | ||||||
|---|---|---|---|---|---|---|
| C=265; O=4; E=0.50; R=7.94; rawP=0.0017; adjP=0.0079 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000049130 | NA | KITLG | KIT ligand | 4254 | ENSG00000049130 |
| 2  | ENSG00000150630 | NA | VEGFC | vascular endothelial growth factor C | 7424 | ENSG00000150630 |
| 3  | ENSG00000168329 | NA | CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 1524 | ENSG00000168329 |
| 4  | ENSG00000113594 | NA | LIFR | leukemia inhibitory factor receptor alpha | 3977 | ENSG00000113594 |
| Database:KEGG pathway       Name:Chemokine signaling pathway       ID:04062 | ||||||
|---|---|---|---|---|---|---|
| C=189; O=3; E=0.36; R=8.35; rawP=0.0057; adjP=0.0119 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000168329 | NA | CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 1524 | ENSG00000168329 |
| 2  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 3  | ENSG00000118689 | NA | FOXO3 | forkhead box O3 | 2309 | ENSG00000118689 |
| Database:KEGG pathway       Name:Non-small cell lung cancer       ID:05223 | ||||||
|---|---|---|---|---|---|---|
| C=54; O=2; E=0.10; R=19.48; rawP=0.0048; adjP=0.0119 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 2  | ENSG00000118689 | NA | FOXO3 | forkhead box O3 | 2309 | ENSG00000118689 |
| Database:KEGG pathway       Name:Inositol phosphate metabolism       ID:00562 | ||||||
|---|---|---|---|---|---|---|
| C=57; O=2; E=0.11; R=18.45; rawP=0.0053; adjP=0.0119 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000133056 | NA | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta | 5287 | ENSG00000133056 |
| 2  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| Database:KEGG pathway       Name:Endometrial cancer       ID:05213 | ||||||
|---|---|---|---|---|---|---|
| C=52; O=2; E=0.10; R=20.23; rawP=0.0045; adjP=0.0119 | ||||||
| Index | UserID | Value | Gene Symbol | Gene Name | EntrezGene | Ensembl |
| 1  | ENSG00000105851 | NA | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 5294 | ENSG00000105851 |
| 2  | ENSG00000118689 | NA | FOXO3 | forkhead box O3 | 2309 | ENSG00000118689 |
WebGestalt is currently developed and maintained by Jing Wang and Bing Zhang at the Zhang Lab. Other people who have made significant contribution to the project include Dexter Duncan, Stefan Kirov, Zhiao Shi, and Jay Snoddy.
Funding credits: NIH/NIAAA (U01 AA016662, U01 AA013512); NIH/NIDA (P01 DA015027); NIH/NIMH (P50 MH078028, P50 MH096972); NIH/NCI (U24 CA159988); NIH/NIGMS (R01 GM088822).